Gene · 57733
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bottom-Up Proteomics: Advancements in Sample Preparation. | Int J Mol Sci | 2023 | 36982423 | PubTator, text mining | PubMed |
| Advancing Luciferase-Based Antibody Immunoassays to Next-Generation Mix and Read Testing. | Biosensors (Basel) | 2023 | 36979515 | PubTator, text mining | PubMed |
| The Chelating Ability of Plant Polyphenols Can Affect Iron Homeostasis and Gut Microbiota. | Antioxidants (Basel) | 2023 | 36978878 | PubTator, text mining | PubMed |
| Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis. | BMC Med Genomics | 2023 | 36978098 | PubTator, text mining | PubMed |
| Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2. | Eur J Med Chem | 2023 | 36965227 | PubTator, text mining | PubMed |
| Global detection of human variants and isoforms by deep proteome sequencing. | Nat Biotechnol | 2023 | 36959352 | PubTator, text mining | PubMed |
| Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia. | Signal Transduct Target Ther | 2023 | 36959211 | PubTator, text mining | PubMed |
| Engineered exosomes from different sources for cancer-targeted therapy. | Signal Transduct Target Ther | 2023 | 36922504 | PubTator, text mining | PubMed |
| Simultaneous expression of three reporter proteins from a porcine reproductive and respiratory syndrome virus-based vector. | J Virol Methods | 2023 | 36921673 | PubTator, text mining | PubMed |
| A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance. | Sci Adv | 2023 | 36921044 | PubTator, text mining | PubMed |
| Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells. | Proc Natl Acad Sci U S A | 2023 | 36920923 | PubTator, text mining | PubMed |
| Revealing geographic transmission pattern of COVID-19 using neighborhood-level simulation with human mobility data and SEIR model: A case study of South Carolina. | Int J Appl Earth Obs Geoinf | 2023 | 36908290 | PubTator, text mining | PubMed |
| DeepDetect: Deep Learning of Peptide Detectability Enhanced by Peptide Digestibility and Its Application to DIA Library Reduction. | Anal Chem | 2023 | 36908083 | PubTator, text mining | PubMed |
Probing the E1o-E2o and E1a-E2o Interactions in Binary Subcomplexes of the Human 2-Oxoglutarate Dehydrogenase and 2-Oxoadipate Dehydrogenase Complexes by Chemical Cross-Linking Mass Spectrometry and Molecular Dynamics Simulation. | Int J Mol Sci | 2023 | 36901986 | PubTator, text mining | PubMed |
| The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells. | mSphere | 2023 | 36883841 | PubTator, text mining | PubMed |
| First paleoproteome study of fossil fish otoliths and the pristine preservation of the biomineral crystal host. | Sci Rep | 2023 | 36882485 | PubTator, text mining | PubMed |
| Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques. | Drug Deliv | 2023 | 36880122 | PubTator, text mining | PubMed |
| Raddeanin A Enhances Mitochondrial DNA-cGAS/STING Axis-Mediated Antitumor Immunity by Targeting Transactive Responsive DNA-Binding Protein 43. | Adv Sci (Weinh) | 2023 | 36876644 | PubTator, text mining | PubMed |
| StARD9 is a novel lysosomal kinesin required for membrane tubulation, cholesterol transport and Purkinje cell survival. | J Cell Sci | 2023 | 36861884 | PubTator, text mining | PubMed |
| Interlaboratory Study to Evaluate a Testing Protocol for the Safety of Food Packaging Coatings. | Toxics | 2023 | 36851031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57733/papers?page=10